DR BELLS POMADE (Genomma lab USA Inc.)


Welcome to the PulseAid listing for the DR BELLS POMADE drug offered from Genomma lab USA Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Genomma lab USA Inc.
NON-PROPRIETARY NAME: Triple Antibiotic Plus Pain Relief
SUBSTANCE NAME: BACITRACIN ZINC; POLYMYXIN B SULFATE; NEOMYCIN SULFATE; PRAMOXINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2012-05-16
END MARKETING DATE: 0000-00-00


DR BELLS POMADE HUMAN OTC DRUG Details:

Item DescriptionDR BELLS POMADE from Genomma lab USA Inc.
LABELER NAME: Genomma lab USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500; 10000; 3.5; 10([USP’U]/g; [USP’U]/g; mg/g; mg/g)
START MARKETING DATE: 2012-05-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50066-161_671d14d7-d8b7-4999-94ac-727cb237b564
PRODUCT NDC: 50066-161
APPLICATION NUMBER: part333B

Other BACITRACIN ZINC; POLYMYXIN B SULFATE; NEOMYCIN SULFATE; PRAMOXINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
CVS HealthCVS Health Triple Antibiotic with Pain Relief
Faria LLC dba Sheffield PharmaceuticalsSheffield Triple Antibiotic Plus Pain Relief
Genomma lab USA Inc.DR BELLS POMADE
ProMex LLCCuadriderma